Literature DB >> 19770777

Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes.

W Scott Watkins1, Steven C Hunt, Gordon H Williams, Whitney Tolpinrud, Xavier Jeunemaitre, Jean-Marc Lalouel, Lynn B Jorde.   

Abstract

OBJECTIVES: To better understand the relationship between angiotensinogen (AGT) genetic variation and essential hypertension, AGT genotypes and haplotypes were tested for association with hypertensive endophenotypes and essential hypertension.
METHODS: Two hundred and fifty-six Hypertensive Pathotype (HyperPATH)/Specialized Center of Research (SCOR) cases and 126 controls were genotyped for 24 single-nucleotide polymorphisms (SNPs) in the AGT gene. SNPs and AGT haplotypes were tested for association with plasma AGT, renal plasma flow (RPF), and essential hypertension.
RESULTS: New associations between essential hypertension, plasma AGT, and RPF are reported for alleles -1178G, 6066A, 6152A, 6233C, and 12822C. The maximum odds ratio for association of hypertension and AGT genetic variation was 2.3 [95% confidence interval (CI) 1.5-3.8; P < 0.0003] for allele 6233C. Previous associations for -1074T, -532T, -217A, -6A, and 4072C are confirmed (P < 0.05). Sodium depletion enhances associations between AGT SNPs and plasma AGT. Most individually associated SNPs, including -6A and 4072C, are found on a common complete AGT haplotype, H4 (frequency = 0.09). Individuals with haplotype H4 have significantly higher plasma AGT and reduced RPF (P < 0.003 and P < 0.0002, respectively). Other common haplotypes are not associated with increased plasma AGT levels in this data set despite the presence of the -6A and 4072C alleles, suggesting that AGT haplotype H4 is more predictive of elevated plasma AGT than is -6A or 4072C.
CONCLUSION: This study demonstrates the importance of analyzing haplotypes in addition to single genotypes in association studies. By demonstrating the dependence of AGT associations on sodium depletion status, it helps to explain previous conflicting association results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19770777      PMCID: PMC3025818          DOI: 10.1097/HJH.0b013e328332031a

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  43 in total

1.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

2.  Angiotensinogen gene core promoter variants and non-modulating hypertension.

Authors:  K F Hilgers; C Delles; R Veelken; R E Schmieder
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

3.  Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake.

Authors:  A Raji; G H Williams; X Jeunemaitre; P N Hopkins; S C Hunt; N K Hollenberg; E W Seely
Journal:  J Hypertens       Date:  2001-01       Impact factor: 4.844

4.  Kinetics of the human renin and human substrate reaction.

Authors:  A B Gould; D Green
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

5.  Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations.

Authors:  Toshiaki Nakajima; Lynn B Jorde; Tomoaki Ishigami; Satoshi Umemura; Mitsuru Emi; Jean-Marc Lalouel; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2001-11-30       Impact factor: 11.025

6.  Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.

Authors:  E Mervaala; B Dehmel; V Gross; A Lippoldt; J Bohlender; A F Milia; D Ganten; F C Luft
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

7.  Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension.

Authors:  Paul N Hopkins; Steven C Hunt; Xavier Jeunemaitre; Barbara Smith; Daniel Solorio; Naomi D L Fisher; Norman K Hollenberg; Gordon H Williams
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

8.  Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension.

Authors:  Armindo D Tiago; Nilesh J Samani; Geoffrey P Candy; Richard Brooksbank; Elena N Libhaber; Pinhas Sareli; Angela J Woodiwiss; Gavin R Norton
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

9.  Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans.

Authors:  Sudhir Jain; Xiangna Tang; Chittampalli S Narayanan; Yogesh Agarwal; Stephen M Peterson; Clinton D Brown; Jurg Ott; Ashok Kumar
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Association between evolutionary history of angiotensinogen haplotypes and plasma levels.

Authors:  Laura Fejerman; Nourdine Bouzekri; Xiaodong Wu; Adebowale Adeyemo; Amy Luke; Xiaofeng Zhu; Ryk Ward; Richard S Cooper
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

View more
  19 in total

1.  Revising the M235T polymorphism position for the AGT gene and reporting a modifying variant in the Brazilian population with potential cardiac and neural impact.

Authors:  R R Lemos; S G de Lima; J E Gomes da Cunha; D F Oliveira; M B Rodrigues de Souza; C F J Ayres; M F P M Albuquerque; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2012-04-25       Impact factor: 3.444

Review 2.  Genetic architecture of complex traits predisposing to nephropathy: hypertension.

Authors:  Steven C Hunt
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

3.  Dexamethasone promotes hypertension by allele-specific regulation of the human angiotensinogen gene.

Authors:  Varunkumar G Pandey; Sudhir Jain; Anita Rana; Nitin Puri; Sri Krishna C Arudra; Brahmaraju Mopidevi; Meenakshi Kaw; Alberto Nasjletti; Ashok Kumar
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

4.  Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension.

Authors:  Eros Balam-Ortiz; Adolfo Esquivel-Villarreal; David Huerta-Hernandez; Juan Carlos Fernandez-Lopez; Luis Alfaro-Ruiz; Omar Muñoz-Monroy; Ruth Gutierrez; Enrique Figueroa-Genis; Karol Carrillo; Adela Elizalde; Alfredo Hidalgo; Mauricio Rodriguez; Maki Urushihara; Hiroyuki Kobori; Gerardo Jimenez-Sanchez
Journal:  Hypertension       Date:  2012-02-27       Impact factor: 10.190

5.  A polymorphism in intron I of the human angiotensinogen gene (hAGT) affects binding by HNF3 and hAGT expression and increases blood pressure in mice.

Authors:  Brahmaraju Mopidevi; Meenakshi K Kaw; Indu Sivankutty; Sudhir Jain; Sravan Kumar Perla; Ashok Kumar
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

Review 6.  Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies.

Authors:  Aldi T Kraja; Steven C Hunt; D C Rao; Victor G Dávila-Román; Donna K Arnett; Michael A Province
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

7.  Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population.

Authors:  Eros Balam-Ortiz; Adolfo Esquivel-Villarreal; Luis Alfaro-Ruiz; Karol Carrillo; Adela Elizalde; Trinidad Gil; Maki Urushihara; Hiroyuki Kobori; Gerardo Jimenez-Sanchez
Journal:  Am J Med Sci       Date:  2011-09       Impact factor: 2.378

8.  Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).

Authors:  Hiroyuki Kobori; Maki Urushihara; Ji H Xu; Gerald S Berenson; Luis Gabriel Navar
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

9.  CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow.

Authors:  Jonathan S Williams; Paul N Hopkins; Xavier Jeunemaitre; Nancy J Brown
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

Review 10.  The renin angiotensin aldosterone system and insulin resistance in humans.

Authors:  Patricia C Underwood; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.